NEW YORK (AP) — Stocks that moved heavily or traded substantially Monday:
Moderna Inc., up $25.71 to $152.74.
The biotechnology company said it would ask U.S. and European regulators to allow emergency use of its COVID-19 vaccine.
S&P Global Inc., up $10.21 to $351.78.
The financial information company is buying data provider IHS Markit in a $44 billion all-stock deal.
Slack Technologies Inc., up $2.21 to $42.88.
Salesforce.com is reportedly preparing to buy the work-messaging company, according to media reports.
Nikola Corp., down $7.52 to $20.41.
General Motors abandoned a planned $2 billion investment in the electric vehicle maker.
JetBlue Airways Corp., down 62 cents to $15.09.
The airline warned investors its revenue would fall sharply during the fourth quarter.
Facebook Inc., down 84 cents to $276.97.
The social media company faces new federal and state antitrust lawsuits, according to the Wall Street Journal.
Carnival Corp., down $1.60 to $19.98.
Concerns over rising virus cases weighed on cruise line operators and other companies that depend on travelers.
Novavax Inc., up $13.81 to $139.50.
The biotechnology company gave investors an encouraging update on its program to develop a COVID-19 vaccine.
slowdown in store traffic but strong online spending.
Before you consider Novavax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novavax wasn't on the list.
While Novavax currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.
Get This Free Report
